Nevro Corp NVRO

NYS: NVRO | ISIN: US64157F1030   2/04/2025
5,840 USD (0,00%)
(0,00%)   2/04/2025

4 maart 2025 · Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results · Persbericht

28 augustus 2024 · Nevro to Present at Wells Fargo 2024 Healthcare Conference · Persbericht

14 augustus 2024 · Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 · Persbericht

6 augustus 2024 · Nevro Reports Second-Quarter 2024 Financial Results · Persbericht

11 juli 2024 · Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 · Persbericht

9 juli 2024 · Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 · Persbericht

28 juni 2024 · Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 · Persbericht

11 juni 2024 · Nevro to Present at Truist Securities MedTech Conference · Persbericht

24 mei 2024 · Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 · Persbericht

9 mei 2024 · Nevro to Present at BofA Securities 2024 Healthcare Conference · Persbericht

7 mei 2024 · Nevro Reports First-Quarter 2024 Financial Results · Persbericht

17 april 2024 · Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024 · Persbericht

28 februari 2024 · Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw · Persbericht

21 februari 2024 · Nevro Enters Into Cooperation Agreement With Engaged Capital · Persbericht

21 februari 2024 · Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results · Persbericht

1 februari 2024 · Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy · Persbericht

29 januari 2024 · Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024 · Persbericht

18 januari 2024 · Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy · Persbericht

17 januari 2024 · Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting · Persbericht

9 januari 2024 · Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results · Persbericht

Mijn selecties